Curis (CRIS) Proxy filing summary

Executive summary

• Stockholders will consider a 1-for-5 to 1-for-12 reverse split, with the board authorized to select the ratio and implementation timing within six months of approval.

• The board’s primary rationale is to support Nasdaq’s minimum bid-price requirement; it also expects a higher share price may broaden investor interest, though no lasting increase is assured.

Voting matters and shareholder proposals

• The Nov. 18, 2026 virtual special meeting has two proposals: approve the reverse split amendments and authorize adjournment to solicit additional votes if needed.

• Each proposal requires a majority of votes cast; abstentions have no effect, and the board recommends FOR both.

• The record date is Oct. 26, 2026, with 6,679,229 common shares outstanding and one vote per share.

Board of directors and corporate governance

• The board may choose any approved ratio, set the implementation timing, or abandon the amendments; the certificate must be filed within six months after stockholder approval.

• The board intends to implement the reverse split if approved, while retaining authority to abandon it if it determines the action is no longer in stockholders’ best interests.